Artificial Intelligence in Healthcare Market to reach $765 Million by 2030; increasing prevalence of chronic diseases, advancements in healthcare IT, and growing investments in AI technologies are driving the market

The Artificial Intelligence (AI) in Healthcare Market size is projected to reach $333.7 Billion by 2030, growing at a CAGR of 48.0% during the forecast period 2024–2030, according to a recent report published by IndustryARC, titled “AI in Healthcare Market – By Deployment(On Premise, On Cloud, Hybrid), By Components (Hardware, Software, Services), By Technology (Machine Learning, Deep Learning, Natural Language Processing, Others), By Operation Model (Unsupervised, Supervised, Reinforced, Semi supervised, Others), By Application (Disease identification and diagnosis, Personalized treatment and behavior modification, Drug discovery and manufacturing, Clinical trial research, Radiology and Radiotherapy, Smart electronic health record, Epidemic outbreak prediction, Virtual nurses, Repetitive jobs, Others), By Geography – Global Opportunity Analysis & Industry Forecast, 2024–2030.”

AI technologies are transforming healthcare, enabling more precise diagnostics, automating administrative tasks, and optimizing patient care pathways. The growth of the market is driven by increasing investments in AI R&D, rising adoption of wearable technology, and the expansion of telemedicine services globally.

North America accounted for the largest share, approximately 40%, of the AI in Healthcare Market in 2023. The region's dominance is driven by a well-established healthcare infrastructure, significant R&D investments, and supportive government policies promoting AI adoption. According to the U.S. Department of Health and Human Services, investments in AI for medical imaging and diagnostics have grown by over 20% annually since 2020. Moreover, AI-powered remote patient monitoring solutions have been widely adopted, particularly in chronic disease management, with reports from the Journal of Medical Internet Research showing a 30% reduction in hospital readmissions among users of AI-driven health monitoring systems in the United States.

Artificial Intelligence is revolutionizing precision medicine by enabling the development of highly tailored treatment plans based on an individual's unique genetic makeup, environmental factors, and lifestyle choices. AI algorithms analyze vast amounts of genomic data, identifying biomarkers for diseases such as cancer and rare genetic disorders. For example, AI-driven platforms like IBM Watson Genomics assist oncologists in selecting targeted therapies, improving survival rates. According to the National Cancer Institute, precision medicine approaches in oncology have led to a 10% improvement in treatment efficacy. This AI-driven transformation is not limited to oncology but extends to managing autoimmune disorders, cardiovascular diseases, and more.

AI-powered remote patient monitoring (RPM) systems are enhancing chronic disease management by integrating wearable devices and Internet of Things (IoT) technologies. These systems collect real-time health data, such as heart rate, glucose levels, and blood pressure, which are analyzed using AI to detect early signs of complications. For instance, the use of AI-based RPM for diabetes has reduced hospital readmissions by 25%, as reported by a 2023 study published in The Lancet Digital Health. Furthermore, AI-driven RPM platforms, like Biofourmis and Fitbit Health Solutions, empower patients with actionable insights, improving health outcomes while reducing the burden on healthcare facilities.

Key companies profiled in the Artificial Intelligence (AI) in Healthcare Market are Google Inc., IBM, Butterfly Network, GE Healthcare, Tempus, CloudMedX and others

Oral Care Market - Oral Care Market Size is forecast to reach $ 54200 Million by 2030, at a CAGR of 6.70% during forecast period 2024-2030. Rising pediatric and geriatric dental problems, owing to changing lifestyles and modern food habits, is majorly influencing the global oral care market.

Augmented Reality & Virtual Reality in Healthcare Market - Augmented Reality & Virtual Reality in Healthcare Market Size is forecast to reach $ 6505.8 Million by 2030, at a CAGR of 14.40% during forecast period 2024-2030.

Biomarkers Market- Biomarkers are biological molecules which act as indicator of a particular disease state or pharmacological conditions. Advancement in post genomic technologies, increasing R&D spending and dynamic applications of biomarkers in medicine will drive the future market growth.